Literature DB >> 3494672

Generation of lymphokine-activated killer cells does not require DNA synthesis.

M Malkovský, M Jíra, J Madar, V Malkovska, B Loveland, G L Asherson.   

Abstract

We studied the role of DNA synthesis in the induction of lymphokine-activated killer (LAK) cells by recombinant interleukin-2 (IL-2) and the dependence of this phenomenon on DNA synthesis. Doses of gamma-irradiation (1000-5000 rads) that profoundly reduced DNA synthesis in human peripheral blood mononuclear leucocytes (PBL) also effectively suppressed the development of cytotoxic activity in the absence of IL-2. However, the same doses of irradiation affected the induction of LAK activity by IL-2 to a much lesser extent. Blocking the formation of deoxyribonucleotides by hydroxyurea, which resulted in a complete inhibition of DNA synthesis in PBL or purified T lymphocytes, had virtually no effect on the generation of LAK cells. These results indicate that the expression of LAK activity is not dependent on DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494672      PMCID: PMC1453248     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

Review 1.  Reduction of ribonucleotides.

Authors:  L Thelander; P Reichard
Journal:  Annu Rev Biochem       Date:  1979       Impact factor: 23.643

2.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

3.  Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2.

Authors:  M Malkovsky; G L Asherson; B Stockinger; M C Watkins
Journal:  Nature       Date:  1982-12-16       Impact factor: 49.962

4.  In vivo and in vitro administration of interleukin 2-containing preparation reverses T-cell unresponsiveness in Mycobacterium bovis BCG-infected mice.

Authors:  V Colizzi
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

Authors:  M A Cheever; P D Greenberg; A Fefer; S Gillis
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

6.  A diet enriched in vitamin A acetate or in vivo administration of interleukin-2 can counteract a tolerogenic stimulus.

Authors:  M Malkovský; P Medawar; R Hunt; L Palmer; C Doré
Journal:  Proc R Soc Lond B Biol Sci       Date:  1984-02-22

7.  Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate.

Authors:  M Malkovský; C Doré; R Hunt; L Palmer; P Chandler; P B Medawar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  HYDROXYUREA: INHIBITORY EFFECT ON DNA METABOLISM.

Authors:  C W YOUNG; S HODAS
Journal:  Science       Date:  1964-11-27       Impact factor: 47.728

9.  Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2.

Authors:  J J Mulé; S Shu; S L Schwarz; S A Rosenberg
Journal:  Science       Date:  1984-09-28       Impact factor: 47.728

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  9 in total

Review 1.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

2.  Isolation and functional characterization of chicken intestinal intra-epithelial lymphocytes showing natural killer cell activity against tumour target cells.

Authors:  J Y Chai; H S Lillehoj
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

3.  Differential effects of various cytokines on the generation of rat LAK cells from their purified precursors.

Authors:  A A Maghazachi
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

4.  Generation of lymphokine-activated killer cells in long-term cultures.

Authors:  M Hartwig; I J Körner
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

5.  Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production.

Authors:  B Brooks; K Chapman; J Lawry; A Meager; R C Rees
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

6.  The inhibitory effect of human interferon alpha on the generation of lymphokine-activated killer activity.

Authors:  Y Tokuda; N Ebina; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity.

Authors:  B Brooks; R C Rees
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

8.  Role of proliferation in LAK cell development.

Authors:  F J Ramsdell; H Shau; S H Golub
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

9.  Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines.

Authors:  P J Guillou; C W Ramsden; S S Somers; P C Sedman
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.